Biodistribution of post-therapeutic versus diagnostic131I-MIBG scans in children with neuroblastoma-Reference-Cited by-同舟云学术

Biodistribution of post-therapeutic versus diagnostic131I-MIBG scans in children with neuroblastoma

Published:2004-03 Issue:3 Volume:42 Page:268-274
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Hickeson Marc P.,Charron Martin,Maris John M.,Brophy Patricia,Kang Tammy I.,Zhuang Hongming,Khan Jehanzeb,Nevrotski Teresa

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference36 articles.

1. Cancer incidence, survival, and mortality for children younger than age 15 years

2. et al. Solid tumors of childhood. In: editors. Cancer: Principles and practice of oncology. 4th edn. Philadelphia, PA: Lippincott; 1993. pp 1738-1791.

3. 131I MIBG therapy in neuroblastoma: Mechanisms, rationale, and current status

4. Treatment of neuroblastoma stage 4 with 131I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radionuclide Therapy in Neuroectodermal Tumors;Radionuclide Therapy;2022

2. Diagnostic Use of Post-therapy 131I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma;Diagnostics;2020-09-02

3. High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience;Annals of Nuclear Medicine;2020-08-29

4. Radioisotope Therapies: Iodine-131, I-131-MIBG, and Beyond;Pediatric Oncology;2019

5. SPECT/CT MIBG Imaging Is Crucial in the Follow-up of the Patients With High-Risk Neuroblastoma;Clinical Nuclear Medicine;2018-04